Shared by
beno
Fundamentals
N/a
Catalysts / News / Painting the picture
-Corona virus sympathy
-Health officials say virus vaccine development has 'no glitches'
-Feb 11 2020: $500m IPO @ $19 per share
-mRNA-1273 coronavirus vaccine sent for testing
-March 16 2020: First human trial of COVID-19 vaccine
-April 15 2020: PT increase to 41, Making new ATH's
-April 16 2020: Wins $483 Million US Government Award To Develop Coronavirus Vaccine
-May 01 2020: Moderna and Lonza Announce Worldwide Strategic Collaboration to Manufacture Modernas Vaccine (mRNA-1273)
-May 06 2020: Weak earnings / lags estimates, FDA approves phase 2 of COVID-19 vaccine
Technical Analysis
-SPY pattern: Afternoon Runner
-Intraday pattern: Afternoon Runner
-Levels: 57, 58, 61.5
Strategy / Confluence / Sizing Guide / Risk
Strategy: First test long of 58
Confluence: Whole $
Strike Zone: 58.15 - 58
Sizing (lots): 3
Risk (stop / Rs): Hold below 58
Review / Lessons Learned
OGT, scaled in and scaled out.
Execution detail:
| Date/time | Symbol | Side | Price | Position |
|---|---|---|---|---|
| 2020-05-29 12:45:54 | MRNA | buy | $58.280 | long |
| 2020-05-29 12:46:00 | MRNA | buy | $58.200 | long |
| 2020-05-29 12:46:02 | MRNA | buy | $58.110 | long |
| 2020-05-29 12:46:41 | MRNA | sell | $58.340 | long |
| 2020-05-29 12:46:52 | MRNA | sell | $58.430 | long |
| 2020-05-29 12:47:12 | MRNA | sell | $58.550 | 0 |
Leave a comment about this trade!
You need to log into your Tradervue account to leave a comment. If you don't have one,
it takes
just a few seconds to sign up, and it's free!